Trial intelligence / Profile preview

ED50 and ED95 determination of cyclopofol for painless gastrointestinal endoscopy in elderly patients

ChiCTR2100047354Phase 4Not yet recruiting

Sponsor
Sir Run-Run Shaw Hospital
Start
Jul 2021
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ciprofol in gastrointestinal conditions (3 arms), sponsored by Sir Run-Run Shaw Hospital. Primary endpoints: Dosage of cyclopofol and Incidence of injection pain. Planned start Jul 2021; status: not yet recruiting.

02

Drugs

ciprofol
03

Conditions

gastrointestinal conditions

Beyond the preview

Go deeper on ChiCTR2100047354.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100047354.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call